Cargando…
Risk assessment in systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
OBJECTIVE: This study evaluated the prognostic value of the multivariable risk assessment for systemic lupus erythematosus (SLE)-associated pulmonary arterial hypertension (PAH). METHODS: A multicenter prospective cohort of SLE-associated PAH (CSTAR-PAH cohort) diagnosed based on right heart cathete...
Autores principales: | Wang, Qian, Qian, Junyan, Li, Mengtao, Zhang, Xiao, Wei, Wei, Zuo, Xiaoxia, Zhu, Ping, Ye, Shuang, Zhang, Wei, Zheng, Yi, Qi, Wufang, Li, Yang, Zhang, Zhuoli, Ding, Feng, Gu, Jieruo, Liu, Yi, Huang, Can, Zhao, Jiuliang, Liu, Yongtai, Tian, Zhuang, Wang, Yanhong, Zhang, Miaojia, Zeng, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310292/ https://www.ncbi.nlm.nih.gov/pubmed/35898921 http://dx.doi.org/10.1177/20406223221112528 |
Ejemplares similares
-
A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
por: Qu, Jingge, et al.
Publicado: (2023) -
Validation of the REVEAL Prognostic Models in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension
por: Qu, Jingge, et al.
Publicado: (2021) -
Long-term Outcomes of Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study from CSTAR Registry
por: Wang, Ziqian, et al.
Publicado: (2021) -
Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus
por: Li, Mengtao, et al.
Publicado: (2021) -
Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
por: Jiang, Nan, et al.
Publicado: (2022)